Klotho Therapeutics Company
Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
Biotechnology, Health Care
Investors Number:
1
Last Funding Date:
2017
Technology:
Geroscience
Founded Date:
2016
Investor Type:
Early Stage Venture
Headquarters:
San Diego, California, United States
Total Funding:
10000000
Last Funding Type:
Series A
Employee Number:
1-10